MDGL

NASD Madrigal Pharmaceuticals, Inc.
Oct 5, 2026 · 6:40 PM ET LAST TRADE Market Closed

$490.09 ↓ -3.53 (-0.71%) Trading Down from the previous close of $493.62, $14.91 below the day’s high of $505.00

YTD change
-15.84%
vs 20-day SMA
-6.30%
vs 200-day SMA
-4.02%

Price ranges

Previous day
$491.05 $505.00
open $505.00 close $499.40
-$5.60 (-1.11%)
Today
$491.25 $505.00
open $501.89 now $490.09
-$11.80 (-2.35%)
Past week
$491.05 $525.00
from $516.56 now $490.09
-$26.47 (-5.12%)
Past month
$491.05 $549.97
from $542.61 now $490.09
-$52.52 (-9.68%)
This year
$416.21 $598.79
from $582.34 now $490.09
-$92.25 (-15.84%)

Price & Performance

-34.48 (-6.46%) / 6M

$443.86$487.37$530.89$574.40Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 20.3% away from all-time highs of $615.00
  • MDGL is down 16% since the beginning of the year
  • MDGL is up 11% over the past 12 months
  • MDGL is down 10% over the past 1 month
  • 10% of all MDGL investors are betting against MDGL

MDGL reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +12.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.99
Earnings momentum -137.0% Quarterly EPS growth
Quarterly change -137.0%

Valuation

P/E ratio N/A
Enterprise value $14.1B
Beta 1.41

Balance sheet & scale

IncomeN/A
Revenue$1.3B
Cash$838.9M
Debt$347.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $11.3B

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $735.20 +0.05%
IQV IQVIA Holdings Inc $258.21 -0.96%
CRL Charles River Laboratories International, Inc. $290.19 +1.17%
ICLR ICON Plc $162.05 +0.12%
IT Gartner, Inc. $184.80 -4.15%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.